Release Date: 01/08/11 09:00 Summary: Quarterly Activities and Cashflow Report Price Sensitive: Yes Download Document 1.71MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%